Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.
Also called NCT03299296
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03299296
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03299296. Randomized; single masking; primary purpose prevention. Start 2017-01-01 (actual); primary completion 2018-01-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
- Condition
- Thromboses, Deep Vein
- Condition
- Surgery--Complications
- Intervention (Drug)
- Rivaroxaban 10 Milligrams
- Intervention (Drug)
- Enoxaparin 40 Milligrams/0.4 Milliliters Prefilled Syringe
- Lead sponsor
- Ahmed AbdelMoneim Hassan Ali
- Collaborator
- Beni-Suef University
Record details
- Record id
cardio:ct-nct03299296- Content hash
66ffb4d929063536f99967c0b9fef6b1a5ec46fb4903693dc34faceda3a588cd